Three months to see an endocrinologist on a high-deductible plan?

The referral said endocrinology. The scheduler said the first opening was three months out. Your plan carries a deductible between $5,000 and $10,000, so in most years you pay for nearly every visit and every lab yourself. Then an advertisement offers a clinician this week for $99 a month. The reasoning writes itself. If you are paying cash anyway, the cheapest cash option should win. This piece tests that reasoning for one situation and prices both sides with dated figures. The situation is waiting to see an endocrinologist on a high-deductible plan.

The person described here is a composite drawn from situations like yours. No real patient is described. Our position comes first so you can weigh the numbers knowing it. GoodLife Health is a clinician-led membership at $299 a month that pairs with your insurance for catastrophic cover and replaces the primary-care relationship. It replaces neither the insurance nor the endocrinologist. A $99 app costs less each month. Nothing below argues otherwise. What follows compares what each fee buys and how each business is paid once a prescription is filled.

Three months on the calendar and every bill paid in cash

A high deductible changes how a person buys care. The Kaiser Family Foundation's 2025 Employer Health Benefits Survey puts the average employee deductible at $1,886. Yours sits far above that figure. In practice, the insurance you pay for works mainly as protection against a large event such as a hospital stay. The visit that produced your referral was, for practical purposes, yours to pay. So were the labs drawn at it. So is most of what happens before the specialist.

You already buy care the way you buy anything else, then. You compare prices. You notice when a fee is high and the service is thin. The Learning Center's ROI guide puts insurance-based primary care at 8–18 minutes a visit. In the composite, the visit sat at the short end of that range. It ended with a referral and a date in place of a plan.

The pattern behind the referral was ordinary. The primary-care clinician noticed an A1C drifting upward alongside weight that would not move despite steady effort. The clinician judged the pattern worth a specialist's look. Nobody did anything wrong. A referral is a reasonable step and often the right one.

The trouble is what the referral leaves behind. The months between now and the appointment are empty. No new panel is scheduled. Nobody follows the numbers. The next piece of information arrives with the specialist. Part of that first visit may then go to ordering labs that could have been drawn in the meantime.

You may have opened the result in the portal more than once. You may have looked up the range printed beside it and wondered what three more months will do to it. That is a reasonable thing to wonder. It is also a question nobody is assigned to answer until the appointment.

None of this is an emergency. This piece will not treat it as one. It is a gap of three months in which a question sits at the back of your mind at work and at home. People reasonably try to fill a gap like that.

Into that gap comes the $99 app. It offers speed and a low monthly fee, often with a prescription at the end of a short intake. To someone who has just been told to wait three months, it can look like the same care sooner and for less money. The objection this piece answers is that the $99 app is the same thing. It deserves a real answer. For some people, the app is the right purchase. The section near the end says who they are.

What a $99 fee buys and what pays for the rest

The fee on an advertisement is rarely the monthly cost. The Learning Center's guide to the true monthly cost of GLP-1 telehealth adds three lines for every model: the clinical fee, the medication and the labs. A comparison that leaves out any of the three is marketing.

Whether two services are the same thing comes down to a few questions. The first is whether labs are drawn and read before anything is prescribed. The second is whether the clinician you see this month is the one who reads your next panel. The third is how the business is paid when a prescription is filled. Price is a fourth question. It is the only one the advertisement answers.

Two $99 offers appear in that guide's chart, both at prices published in August 2026. Found lists a $99-a-month platform fee. With compounded semaglutide or liraglutide at $199 to $299 a month on top, its all-in cost came to $298 to $398 a month. Sesame's Success program costs $99 every 28 days and includes consults, basic labs and messaging. Branded medication is bought separately through the manufacturer, which brought its all-in figure to about $448 a month on Wegovy.

Neither Learning Center guide publishes a year-one total for either offer. We will not invent one. A year of either is a year of fees plus the medication. In both cases, the medication is the larger line.

The floor for the medication itself is public. As of September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after that. The Wegovy pill starts at $149 a month at lower doses. Through LillyDirect, Zepbound vials cost $299 to $449 a month depending on dose. Branded medication now has a published self-pay price from the company that makes it, whoever writes the prescription.

The more useful question is how each business is paid. The Learning Center's ROI guide found that GLP-1 subscription telehealth commonly advertises a low fee and recovers its margin on the drug. That arrangement is legal and widespread. It also ties what the business earns to what gets prescribed. In that model, a patient is entitled to ask who benefits when the dose goes up. Not every low-fee offer works this way. Where the medication is bought separately from the manufacturer, the fee and the drug already sit apart.

GoodLife Health is paid by its fee alone. Medication is prescribed, when clinically indicated, to the pharmacy you choose at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. The fee is the same whatever medication is indicated and whatever the dose, with no molecule upcharge and no dose upcharge. This does not make the membership cheaper. It means nobody at GoodLife Health benefits from a prescription.

The lower all-in figure in the chart comes with compounded medication. That choice deserves a plain answer. GoodLife Health prescribes branded, FDA-approved medication only. It never prescribes compounded GLP-1. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss. A clinician's license carries the responsibility for what is prescribed under it. Patients who used compounded medication did nothing wrong. We hold the position for our own prescribing and explain it to anyone who asks.

For someone waiting on a specialist, the missing piece is usually information. The markers need to be measured and then read by someone who will still be reading them next quarter. Medicine is moving toward testing before treating. ApoB is now drawn where an LDL figure once stood alone. Fasting insulin is drawn where fasting glucose was once the only signal, so that a problem can be measured before glucose turns abnormal. Membership care is replacing the eight-minute visit with a clinician who follows the same markers every 90 days.

What $299 a month does with the three months

In the composite, the months before the endocrinology appointment would run like this. The path starts with the eligibility check, the intake and the checkout, then a clinician's review. Not everyone is accepted. Once accepted, the patient has a clinician licensed in all 50 states who orders the first cardiometabolic panel. That panel is one of four a year. Every result is in the patient's hands.

The clinician reads Hemoglobin A1c (HbA1c) and Fasting Insulin together. The panel also includes Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP and TSH With Reflex To Free T4. For the composite reader, the drifting Hemoglobin A1c (HbA1c) is read beside Fasting Insulin and followed every 90 days.

The clinician goes through the results by video and answers questions by message between visits. If medication is clinically indicated, the clinician prescribes branded, FDA-approved medication to the patient's chosen pharmacy at that pharmacy's price. If it is not indicated, nothing is prescribed. The fee is the same either way.

When the endocrinology date arrives, keep it. You arrive with results already drawn and read by a clinician who has followed them. The specialist's opinion still matters. The membership does not stand in for it.

For a person on a high-deductible plan, the division of labor is the point. GoodLife Health pairs with insurance for catastrophic cover and replaces the primary-care relationship. The insurance carries the risk of the large event. The membership carries the ongoing work of measuring, reading and adjusting, at a fee that does not change with the result.

The membership does not replace insurance. Hospital care, specialists and imaging still run through your plan. Whether insurance covers any medication is between you, your plan and your pharmacy. Coverage is never promised. Prior authorization is the pharmacy's process. GoodLife Health does not claim to run it or speed it. The membership promises no particular weight loss and no remission. It is precision direct primary care for cardiometabolic optimization, so it does not take on every complaint a general practice would.

If you hold a health savings account, read this part carefully. We don't promise the membership fee is HSA or FSA eligible. Your account administrator decides, so check with them before using those funds.

The year-one arithmetic is short. The membership is $3,588 a year, plus whatever your pharmacy charges for any medication prescribed. That figure is the whole membership cost. Your insurance stays in place for the large events it was bought to cover.

A plan for this week, whichever you choose

Whether or not you join, a few steps this week will make the three months more useful.

• Ask the endocrinology office to add you to its cancellation list.
• Ask your primary-care office for copies of every result so far, with the dates they were drawn.
• Write down what has changed and when: weight, sleep, energy and anything else the specialist should hear.
• Before paying any app, ours included, ask which labs are drawn before anything is prescribed, whether the same clinician will be there next quarter and how the business is paid when the prescription is filled.
• For any branded medication you are offered, look up the manufacturer's own price and compare it with the app's medication line.
• Call your HSA or FSA administrator before you spend those funds on any membership.

Those questions apply to us as much as to anyone. A membership that cannot answer them plainly has told you something worth knowing.

Who this is not for

Some readers should keep the $99 app or buy nothing at all. If you want a prescription this week and nothing more, an app is built for exactly that. It will cost you less. The ROI guide is plain that a healthy adult who sees a doctor twice a year and takes no medication will not recoup $3,588. If you want compounded GLP-1, we will not prescribe it. If you want a membership to replace your insurance, this is the wrong purchase. If the membership only makes sense to you when paid from an HSA, wait until your administrator has answered. We would sooner say all of this now.

For everyone else, here is the offer in full. The membership is $299 a month, month to month after the first two months. At sign-up, $598 is held on your card and covers those first two months. It is charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy. The fee buys four cardiometabolic panels a year and a clinician who stays. Medication is prescribed to your pharmacy at that pharmacy's price. GoodLife Health takes nothing on it. What the membership returns is the workup a short visit never produced, your markers followed over time and an end to the eight-minute visit. The difference is the order of things: test first, treat second and sell neither the drug nor the dose. The reason to start now is on your calendar. Three months can hold a panel drawn and read before you see the specialist.

Related Reading

• The True Monthly Cost of GLP-1 Telehealth: An Honest Comparison
• The Real ROI of a $299/Month Health Membership: Every Alternative, Priced Honestly

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
4. 2025 Employer Health Benefits Survey — Kaiser Family Foundation. 2025. www.kff.org/health-costs/2025-employer-health-benefits-survey/